Andreas Bruchbacher
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer.
Journal: European urology open science
Published: October 30, 2024
Real-World Results of Cabozantinib Given as Alternative Schedule in Metastatic Renal Cell Carcinoma.
Real-World Results of Cabozantinib Given as Alternative Schedule in Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: August 16, 2023
First-line treatment of metastatic renal cell carcinoma
Journal: Urologie (Heidelberg, Germany)
Published: June 06, 2023
Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis.
Journal: Scientific reports
Published: January 07, 2022
Expression Analysis and Mutational Status of Histone Methyltransferase KMT2D at Different Upper Tract Urothelial Carcinoma Locations.
Journal: Journal of personalized medicine
Published: September 10, 2021
The microbiome in urinary tract infections in children - an update.
Journal: Current opinion in urology
Published: January 15, 2021
First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.
Journal: European urology oncology
Published: December 11, 2020
Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer.
Journal: Cells
Published: July 15, 2020
Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: June 08, 2020
PD1/PD-L1 therapy in metastatic renal cell carcinoma.
Journal: Current opinion in urology
Published: May 27, 2020
Last Updated: 09/26/2026